SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (15965)3/2/1999 1:06:00 AM
From: Nazbuster  Read Replies (2) of 122087
 
Anthony, since you know the drug co's well, what do you think of ZONA? They make a product less effective (but possibly safer) than viagra. Not yet approved by FDA, but they just entered mfg. agreement with Schering Plough.

Possible short?

News: biz.yahoo.com
Quote/chart: quote.yahoo.com
11/16/98 10Q: sec.yahoo.com
WSRN info: wsrn.com

Schering-Plough commenced sales of Vasomax(R) in Mexico under the brand name of Z-Max in June 1998.

Nothing like some guinea pigs prior to FDA approval! Nice ethics!

The Company has experienced negative cash flows from operations since its inception and has funded its activities to date primarily from equity financings and corporate collaborative agreements. ... The Company's ability to raise additional funds in the public or private markets will be adversely affected if the results of its current or future clinical trials and the commercialization of Vasomax(R) are not favorable. The Company may seek additional funding through corporate collaborations and other financing vehicles.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext